Viridian Therapeutics, Inc.\de: which funds bought and sold
Institutions that bought and sold Viridian Therapeutics shares in Q2 2026, from the holdings they reported to the SEC on Form 13F for March 31, 2026 and June 30, 2026.
Between March 31, 2026 and June 30, 2026, 140 institutions that filed 13F reports for both quarters added to or opened positions in Viridian Therapeutics, and 104 cut or closed them. Together they added a net 23.7M shares, +21.1% on what they held at the start of the quarter. Active managers and hedge funds on our list were net buyers of 11.2M shares (+23.0%); index fund managers were net buyers of 4.2M shares (+18.2%). 45 opened a new position and 54 sold out entirely.
Bought, Q2 2026 140 institutions, 45 of them new holders Sold, Q2 2026 104 institutions, 54 of them sold out
Net change, all compared +23.7M shares (+21.1%)
Net change, active managers +11.2M shares (+23.0%), 28 bought, 28 sold
Buyers versus sellers
140 bought 21 104 sold
Active managers and hedge funds 28 bought · 28 sold · +11.2M
Index fund managers 10 bought · 1 sold · +4.2M
Other institutions 102 bought · 75 sold · +8.4M
Biggest buyers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Kynam Capital Management, LP Hedge fund | +4.1M +175.6% | 6.5M | $119M |
| Paradigm Biocapital Advisors LP | +3.6M +113.5% | 6.7M | $124M |
| Price T Rowe Associates Inc Active manager | +2.5M +79.3% | 5.7M | $106M |
| Deep Track Capital, LP Hedge fund | +2.2M +157.7% | 3.6M | $66M |
| Caligan Partners LP Hedge fund | +2.2M New position | 2.2M | $40.3M |
| Point72 Asset Management, L.P. Hedge fund | +2.0M +625.8% | 2.3M | $43M |
| State Street Corp Index funds | +1.5M +31.1% | 6.1M | $113M |
| FMR LLC Active manager | +1.2M +8.0% | 16.6M | $305M |
| Fairmount Funds Management LLC | +1.2M +30.1% | 5.1M | $93.5M |
| UBS Group AG | +1.1M +365.2% | 1.4M | $26.2M |
| Vanguard Portfolio Management LLC Index funds | +1.1M +67.7% | 2.8M | $50.6M |
| Arrowstreet Capital, Limited Partnership Hedge fund | +1.1M +4678.6% | 1.1M | $20.4M |
| Dimensional Fund Advisors LP | +1.1M +204.2% | 1.6M | $29.6M |
| Avoro Capital Advisors LLC Hedge fund | +1.0M +66.7% | 2.5M | $45.9M |
| Candriam S.C.A. | +996K +139.9% | 1.7M | $31.3M |
| Parkman Healthcare Partners LLC | +820K +146.9% | 1.4M | $25.3M |
| Schonfeld Strategic Advisors LLC Hedge fund | +794K New position | 794K | $14.6M |
| First Turn Management, LLC | +759K +83.2% | 1.7M | $30.7M |
| BNP Paribas Financial Markets | +746K +279.9% | 1.0M | $18.6M |
| Blackrock, Inc. Index funds | +720K +9.2% | 8.6M | $157M |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Kynam Capital Management, LP Hedge fund | +4.1M +175.6% | 6.5M | $119M |
| Price T Rowe Associates Inc Active manager | +2.5M +79.3% | 5.7M | $106M |
| Deep Track Capital, LP Hedge fund | +2.2M +157.7% | 3.6M | $66M |
| Caligan Partners LP Hedge fund | +2.2M New position | 2.2M | $40.3M |
| Point72 Asset Management, L.P. Hedge fund | +2.0M +625.8% | 2.3M | $43M |
| FMR LLC Active manager | +1.2M +8.0% | 16.6M | $305M |
| Arrowstreet Capital, Limited Partnership Hedge fund | +1.1M +4678.6% | 1.1M | $20.4M |
| Avoro Capital Advisors LLC Hedge fund | +1.0M +66.7% | 2.5M | $45.9M |
| Schonfeld Strategic Advisors LLC Hedge fund | +794K New position | 794K | $14.6M |
| Renaissance Technologies LLC Hedge fund | +566K +278.4% | 769K | $14.1M |
Biggest sellers
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Citadel Advisors LLC Hedge fund | −2.3M −98.2% | 41K | $758,736 |
| Balyasny Asset Management L.P. Hedge fund | −1.0M −44.7% | 1.3M | $23.5M |
| Adage Capital Partners Gp, L.L.C. Hedge fund | −970K Sold out | 0 | — |
| Loomis Sayles & Co L P Active manager | −928K Sold out | 0 | — |
| Metlife Investment Management, LLC | −656K −92.6% | 53K | $968,264 |
| Federated Hermes, Inc. Active manager | −655K −97.9% | 14K | $261,552 |
| Mpm Bioimpact LLC | −650K Sold out | 0 | — |
| Venrock Adviser, LLC | −625K −16.1% | 3.3M | $59.8M |
| Perceptive Advisors LLC Hedge fund | −589K −50.3% | 582K | $10.7M |
| Deutsche Bank Ag\ | −549K −53.2% | 483K | $8.9M |
| Jpmorgan Chase & Co | −420K −39.6% | 640K | $12.1M |
| Nuveen, LLC | −406K −67.1% | 199K | $3.7M |
| Exoduspoint Capital Management, LP Hedge fund | −330K Sold out | 0 | — |
| ADAR1 Capital Management, LLC Hedge fund | −304K Sold out | 0 | — |
| Pictet Asset Management Holding SA | −303K −96.4% | 11K | $206,203 |
| Davern Capital Partners, LP | −302K Sold out | 0 | — |
| Raymond James Financial Inc | −293K Sold out | 0 | — |
| Marshall Wace, LLP Hedge fund | −270K Sold out | 0 | — |
| Rosalind Advisors, Inc. | −250K Sold out | 0 | — |
| Qube Research & Technologies Ltd Hedge fund | −231K Sold out | 0 | — |
| Institution | Change in shares | Shares June 30, 2026 | Value |
|---|---|---|---|
| Citadel Advisors LLC Hedge fund | −2.3M −98.2% | 41K | $758,736 |
| Balyasny Asset Management L.P. Hedge fund | −1.0M −44.7% | 1.3M | $23.5M |
| Adage Capital Partners Gp, L.L.C. Hedge fund | −970K Sold out | 0 | — |
| Loomis Sayles & Co L P Active manager | −928K Sold out | 0 | — |
| Federated Hermes, Inc. Active manager | −655K −97.9% | 14K | $261,552 |
| Perceptive Advisors LLC Hedge fund | −589K −50.3% | 582K | $10.7M |
| Exoduspoint Capital Management, LP Hedge fund | −330K Sold out | 0 | — |
| ADAR1 Capital Management, LLC Hedge fund | −304K Sold out | 0 | — |
| Marshall Wace, LLP Hedge fund | −270K Sold out | 0 | — |
| Qube Research & Technologies Ltd Hedge fund | −231K Sold out | 0 | — |
New positions
| Institution | Shares | Value June 30, 2026 |
|---|---|---|
| Caligan Partners LPHedge fund | 2.2M | $40.3M |
| Schonfeld Strategic Advisors LLCHedge fund | 794K | $14.6M |
| Boothbay Fund Management, LLCHedge fund | 541K | $9.9M |
| Emerald Advisers, LLC | 537K | $9.9M |
| Ikarian Capital, LLC | 425K | $7.8M |
| Emerald Mutual Fund Advisers Trust | 396K | $7.3M |
| Blue Owl Capital Holdings LP | 260K | $4.8M |
| Capital Fund Management S.A.Hedge fund | 198K | $3.6M |
| F/M Investments LLC | 135K | $2.5M |
| Lighthouse Investment Partners, LLCHedge fund | 120K | $2.2M |
Sold out
| Institution | Shares | Value March 31, 2026 |
|---|---|---|
| Adage Capital Partners Gp, L.L.C.Hedge fund | 970K | $19M |
| Loomis Sayles & Co L PActive manager | 928K | $18.1M |
| Mpm Bioimpact LLC | 650K | $12.7M |
| Exoduspoint Capital Management, LPHedge fund | 330K | $6.5M |
| ADAR1 Capital Management, LLCHedge fund | 304K | $6M |
| Davern Capital Partners, LP | 302K | $5.9M |
| Raymond James Financial Inc | 293K | $5.4M |
| Marshall Wace, LLPHedge fund | 270K | $5.3M |
| Rosalind Advisors, Inc. | 250K | $4.9M |
| Qube Research & Technologies LtdHedge fund | 231K | $4.5M |
Who holds the shares
- Institutions reporting
- 213
- Ten largest holders
- 51.6% of 13F-reported shares
- Index fund managers
- 19.9% of 13F-reported shares
- Active managers and hedge funds
- 43.9% of 13F-reported shares
| Type | Bought | Sold | New | Sold out | Net change in shares | Net % |
|---|---|---|---|---|---|---|
| Active managers and hedge funds | 28 | 28 | 11 | 16 | +11.2M | +23.0% |
| Index fund managers | 10 | 1 | 0 | 0 | +4.2M | +18.2% |
| Other institutions | 102 | 75 | 34 | 38 | +8.4M | +20.5% |
← Back to Viridian Therapeutics, Inc.\de · Insiders · Politicians